v3.24.3
Condensed Consolidated Balance Sheets (Unaudited)
$ in Thousands, € in Millions
Sep. 30, 2024
USD ($)
Dec. 31, 2023
USD ($)
Current assets    
Cash and cash equivalents $ 16,523 $ 45,167
Investment securities, available-for-sale 26,679 28,611
Restricted cash, current 270 3,263
Accounts receivable, net of allowances 232 949
Inventory 4,486 3,874
Other current assets 4,857 4,890
Total current assets 53,047 86,754
Property and equipment, net 7,668 9,032
Operating lease right-of-use assets 12,090 13,758
Restricted cash, net of current portion 1,572 961
Intangible assets, net 12,563 17,235
Other assets 1,322 1,895
Total assets 88,262 129,635
Current liabilities    
Accounts payable 1,487 2,271
Accrued liabilities 5,893 8,640
Accrued liability for Ibeo business combination 6,300
Contract liabilities 180 300
Operating lease liabilities, current 2,149 2,323
Other current liabilities 902 669
Total current liabilities 10,611 20,503
Operating lease liabilities, net of current portion 11,662 12,714
Other long-term liabilities 134 614
Total liabilities 22,407 33,831
Commitments and contingencies (Note 10)
Shareholders’ equity    
Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of September 30, 2024 and December 31, 2023
Common stock, par value $0.001; 310,000 shares authorized; 213,439 and 194,736 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 213 195
Additional paid-in capital 896,424 860,765
Accumulated other comprehensive income 344 210
Accumulated deficit (831,126) (765,366)
Total shareholders’ equity 65,855 95,804
Total liabilities and shareholders’ equity $ 88,262 $ 129,635

Source

HTML PDF
ZIP